She was on chronic treatment with vortioxetine, dextroamphetamine/ amphetamine salts, bupropion, and buspirone upon initiation of tirzepatide 2.5 mg weekly
Same drug, just marketed under a different name, and actually has FDA approval for weight loss indication, whereas Ozempic doesn't
Lancet 402 , 720730 (2023)
And we've been fighting for better therapies ever since then. Now, she credits the combination of metformin, Ozempic (semaglutide), and Farxiga (dapagliflozin) to flattening out her glucose levels, cutting her insulin dose in half, and helping her lose nearly 100 pounds
This dual approach results in better A1c management, greater weight loss, and potentially reduced risk of diabetes complications including kidney disease and cardiovascular events
I ask about personal or family history of medullary thyroid carcinoma and multiple endocrine neoplasia syndrome type 2 because semaglutide carries warnings related to thyroid tumors